Shefali Agarwal
CIK 1746830 · See Remarks · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$29.4K
Companies
3
Total Filings
40
Lifetime Open-Market Net
-$292.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FATE | Director | 10,490 | $2.80 | $29.4K | -$36.8K | 11 | 2026-06-15 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | — | $0.03 | — | $0 | 5 | 2024-06-20 |
| Epizyme, Inc. (EPZM) Delisted | See Remarks | 215,243 | $1.47 | $316.4K | -$255.7K | 22 | 2022-08-11 |
Recent Filings · Page 2 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-13 | FATE | Grant (A) | +8,650 | $0 | EDGAR |
| 2022-06-08 | FATE | Sell (S) | — | $0 | EDGAR |
| 2022-06-08 | FATE | Sell (S) | −841 | -$18.4K | EDGAR |
| 2022-06-06 | FATE | Sell (S) | −807 | -$18.4K | EDGAR |
| 2022-03-21 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +2,331 | $3.0K | EDGAR |
| 2022-02-09 | Epizyme, Inc. (EPZM) Delisted | Sell (S) | −1,058 | -$1.6K | EDGAR |
| 2022-02-04 | Epizyme, Inc. (EPZM) Delisted | Sell (S) | −2,639 | -$3.6K | EDGAR |
| 2022-01-28 | Epizyme, Inc. (EPZM) Delisted | Sell (S) | −2,922 | -$5.9K | EDGAR |
| 2021-12-07 | Epizyme, Inc. (EPZM) Delisted | Sell (S) | −1,780 | -$5.2K | EDGAR |
| 2021-11-19 | Gritstone bio, Inc. (GRTS) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.